Market Overview

Janney Capital Initiates Coverage on BioMarin Pharmaceutical Inc. at Buy, Announces $60.00 PT

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for BMRN

DateFirmActionFromTo
Jun 2015BairdDowngradesOutperformNeutral
Jun 2015BarclaysMaintainsOverweight
Jun 2015Piper JaffrayReiteratesOverweight

View More Analyst Ratings for BMRN
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (BMRN)

Around the Web, We're Loving...

Get Benzinga's Newsletters